Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing novel small-molecule therapies for serious diseases, particularly in oncology and obesity. Their approach is based on clinically validated mechanisms of action and targets indications with significant unmet medical need. Terns possesses a robust pipeline of drug candidates, with several advancing through clinical trials. Notably, TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor, is in development for chronic myeloid leukemia (CML), while TERN-601, an oral GLP-1R agonist, is being investigated for the treatment of obesity.

Terns is characterized by a strong focus on innovation, collaboration, and patient-centricity. Their leadership team comprises experienced drug hunters and developers, committed to advancing transformative medicines. The company fosters a culture of collaboration and inclusion, encouraging cross-functional teamwork across all stages of drug development. Their commitment to ethical practices and open communication is evident in their transparent disclosure of clinical trial results, detailed policies on expanded access, and comprehensive website content addressing various aspects of their operations.

Terns Pharmaceuticals is an equal opportunity employer and, while the website does not explicitly state the company's stance on job flexibility, it encourages candidates to reach out if they are interested in working there. As such, it can be inferred that the company is willing to discuss and explore flexible work arrangements on a case-by-case basis.

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company committed to developing innovative, small-molecule medicines that address serious diseases, particularly in oncology and metabolic diseases. Their approach focuses on clinically validated mechanisms of action and targets indications with significant unmet medical needs, with the ultimate goal of creating transformative treatments for patients worldwide.

Terns Pharmaceuticals fosters a collaborative and inclusive culture that values trust, respect, and growth. They prioritize team-oriented work, encouraging employees to learn and develop their skills, both individually and as a team. The company promotes a high-achieving environment where individuals can soar towards their best, while also fostering strong relationships with colleagues and external partners.

Terns Pharmaceuticals is committed to fostering a culture of collaboration and inclusion, celebrating the diversity of backgrounds, opinions, and experiences within its workforce. The company actively nurtures internal and external relationships and aims to empower employees to be their best while striving to create transformative medicines that address the world's most serious diseases.